Status:
ENROLLING_BY_INVITATION
Fungal Infections During and After the SARS-CoV-2 Pandemic: A Retrospective Comparison
Lead Sponsor:
Bekir Sami Uyanık
Conditions:
Fungal Infections
Eligibility:
All Genders
18+ years
Brief Summary
his study aims to retrospectively compare fungal positivity rates between the SARS-CoV-2 pandemic and the post-pandemic periods. During the pandemic, Candida species had a positivity rate of 17.36%, a...
Detailed Description
The study aims to retrospectively compare fungal positivity rates by focusing on Candida and Aspergillus species during the SARS-CoV-2 pandemic and in the post-pandemic period. The dataset includes sa...
Eligibility Criteria
Inclusion
- Patients over 18 years of age of both genders
Exclusion
- Patients under 18 years of age,
- Patients whose demographic, clinical and laboratory data investigated in the study could not be accessed, patients who were diagnosed with fungal infection during hospitalization
Key Trial Info
Start Date :
June 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 30 2024
Estimated Enrollment :
1441 Patients enrolled
Trial Details
Trial ID
NCT06483815
Start Date
June 1 2024
End Date
July 30 2024
Last Update
July 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hisar Hospital Intercontinental
Istanbul, Turkey (Türkiye), 34768